Last reviewed · How we verify
Selenium& Tacrollimus topical
At a glance
| Generic name | Selenium& Tacrollimus topical |
|---|---|
| Also known as | Group V |
| Sponsor | Al-Azhar University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- The Efficacy of Selenium as an Alternative or Complementary Topical Treatment of Oral Lichen Planus (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Selenium& Tacrollimus topical CI brief — competitive landscape report
- Selenium& Tacrollimus topical updates RSS · CI watch RSS
- Al-Azhar University portfolio CI